Animal drug compounding for animals contains mixing, alerting, and combining ingredients to create drugs tailored to the medical needs of individual animals. Lack of availability of generic veterinary medicine in desired dosage forms for optimum efficiency is driving demand for compounded animal drugs.
The increase in medicinal droughts in required medication levels across the globe as well as the increase in cost of branded prescription equivalents is anticipated to boost the global animal drug compounding market growth over the forecast period. The growing humanization of pets and the increase in adoption of animals in developed nations is expected to propel the growth of animal drug compounding market growth. For instance, in 2015 American Pet product Association had estimated that, families in United States owned 70-80 million dogs & 74-96 million cats. Availability of information makes per owners extremely perspective and therefore increases demand for quality veterinary care will positively influence the market growth during this forecast period.
Lack of trained and skilled medical professionals in animal health space is a primary restraining factor limiting the adoption of animal drug compounding in GCC countries. Also, lack of skilled veterinary compounding medical professionals’ leads to false prescriptions may hamper the market growth.
The Global Animal Drug Compounding Market is segmented into product type such as CNS Agents, Anti-infective Reagents, Anti-Inflammatory Agents, Hormones and Substitutes, and Others, by formulation such as Oral, Injectable, and Others. Further, market is segmented into animal type such as Dogs, Cats, and Others.
Also, the Global Animal Drug Compounding Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are listed in this report such as Triangle Compounding Pharmacy, Medisca, Lorraine's Pharmacy, ESSENTIAL PHARMACY COMPOUNDING VET, Diamondback Drugs of Delaware, LLC, etc.
By Product Type
By Formulation
By Animal Type
By Region
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Animal Drug Compounding Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Animal Drug Compounding Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Animal Drug Compounding Market Share Analysis, By Product Type
5.3 Global Animal Drug Compounding Market Size and Forecast, By Product Type
5.3.1 CNS Agents
5.3.2. Anti-infective Reagents
5.3.3. Anti-Inflammatory Agents
5.3.4 Hormones and Substitutes
5.3.5. Others
6 Global Animal Drug Compounding Market, By Formulation
6.1 Y-o-Y Growth Comparison, By Formulation
6.2 Global Animal Drug Compounding Market Share Analysis, By Formulation
6.3 Global Animal Drug Compounding Market Size and Forecast, By Formulation
6.3.1 Oral
6.3.2. Injectable
6.3.3. Others
7 Global Animal Drug Compounding Market, By Animal Type
7.1 Y-o-Y Growth Comparison, By Animal Type
7.2 Global Animal Drug Compounding Market Share Analysis, By Animal Type
7.3 Global Animal Drug Compounding Market Size and Forecast, By Animal Type
7.3. 1 Dogs
7.3.2. Cats
7.3.3. Others
8Global Animal Drug Compounding Market, By Region
8.1 Global Animal Drug Compounding Market Share Analysis, By Region
8.2 Global Animal Drug Compounding Market Share Analysis, By Region
8.3 Global Animal Drug Compounding Market Size and Forecast, By Region
9 North America Animal Drug Compounding Market Analysis and Forecast (2020-2030)
9.1 Introduction
9.2 North America Animal Drug Compounding Market Share Analysis, By Product Type
9.3 North America Animal Drug Compounding Market Size and Forecast, By Formulation
9.4 North America Animal Drug Compounding Market Size and Forecast, By Animal Type
9.5 North America Animal Drug Compounding Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10EuropeAnimal Drug Compounding Market Analysis and Forecast (2020-2030)
10.1 Introduction
10.2 Europe Animal Drug Compounding Market Share Analysis, By Product Type
10.3 Europe Animal Drug Compounding Market Size and Forecast, By Formulation
10.4 Europe Animal Drug Compounding Market Size and Forecast, By Animal Type
10.5 Europe Animal Drug Compounding Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Animal Drug Compounding Market Analysis and Forecast (2020-2030)
11.1 Introduction
11.2 Asia Pacific Animal Drug Compounding Market Share Analysis, By Product Type
11.3 Asia Pacific Animal Drug Compounding Market Size and Forecast, By Formulation
11.4 Asia Pacific Animal Drug Compounding Market Size and Forecast, By Animal Type
11.5 Asia Pacific Animal Drug Compounding Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Animal Drug Compounding Market Analysis and Forecast (2020-2030)
12.1 Introduction
12.2 Latin America Animal Drug Compounding Market Share Analysis, By Product Type
12.3 Latin America Animal Drug Compounding Market Size and Forecast, By Formulation
12.4 Latin America Animal Drug Compounding Market Size and Forecast, By Animal Type
12.5 Latin America Animal Drug Compounding Market Size and Forecast, Country
13Middle East Animal Drug Compounding Market Analysis and Forecast (2020-2030)
13.1 Introduction
13.2 Middle East Animal Drug Compounding Market Share Analysis, By Product Type
13.3 Middle East Animal Drug Compounding Market Size and Forecast, By Formulation
13.4 Middle East Animal Drug Compounding Market Size and Forecast, By Animal Type
13.5 Middle East Animal Drug Compounding Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Triangle Compounding Pharmacy
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Medisca
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Lorraine's Pharmacy
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 ESSENTIAL PHARMACY COMPOUNDING VET
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Diamondback Drugs of Delaware, LLC
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
